Join our daily newsletter At The Bell to receive exclusive market insights
Race Oncology (ASX:RAC) has captured the most attention on the HotCopper forums today after successfully – and safely – dosing its first patient with RC220 and RC220 in combination with doxorubicin.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
The clinical-stage biopharma company flagged the milestone in its Q4 FY25 report today, where it also confirmed it still has $13.67M in the coffers.
RAC had a tidy run-up on the quarterly release, adding +4.4% to 1.19cps.
West Mits Mining (ASX:WWI) has been trending today too, with the miner unveiling “positive results” from the updated Definitive Feasibility Study it has been running at its Qala Shallows project in Johannesburg.
And, Amplia Therapeutics (ASX:ATX)’s cap raise documents rounded out the top discussions on HotCopper. Amplia halted earlier on Monday for this release.
The local bourse has enjoyed a green day overall; the ASX 200 is up +0.54%.
Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
